Pharmaceutical company Novartis has agreed a deal with Google to develop its smart contact lens aimed at helping diabetics monitor their glucose levels.
The prototype lens, first revealed by the tech giant in January, is designed to measure glucose levels in an individual’s tears before relaying the information to a mobile device or computer. In a move marking Google’s expansion into healthcare applications, it said the prototype has could generate a reading once per second through using a…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
